Lipocine commences ambulatory blood pressure study with Tlando; shares ahead 9% premarket [Seeking Alpha]
Lipocine Inc. (LPCN)
Last lipocine inc. earnings: 11/12 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.lipocine.com
Company Research
Source: Seeking Alpha
Lipocine commences ambulatory blood pressure study with Tlando; shares ahead 9% premarketThinly traded nano cap Lipocine (NASDAQ:LPCN) is up9% premarket on light volume on the heels of itsannouncement that the first patient has been dosed in a clinical trial assessing the effect of TLANDO (testosterone undecanoate) on ambulatory blood pressure in adult males with hypogonadism. Topline data should be available by year-end.Previously:FDA rejects Lipocine's application for TRT med Tlando; shares down 38% premarket (May 9)See all stocks on the move »Now read:Cellectar nabs new U.S. patent covering CLR 131; shares up 11% premarket »
Show less
Read more
Impact Snapshot
Event Time:
LPCN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LPCN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LPCN alerts
High impacting Lipocine Inc. news events
Weekly update
A roundup of the hottest topics
LPCN
News
- Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154 [Yahoo! Finance]Yahoo! Finance
- Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154PR Newswire
- Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
LPCN
Earnings
- 11/8/23 - Miss
LPCN
Sec Filings
- 3/25/24 - Form 8-K
- 3/12/24 - Form 4
- 3/12/24 - Form 4
- LPCN's page on the SEC website